Clinical Trial Update: Improving Memory in Patients With Multiple Sclerosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a memory-improvement intervention for patients with multiple sclerosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Multiple Sclerosis | Phase 3 | Status: WITHDRAWN